Canadian Manufacturing

AI and analytics in surgery market to boost efficiency in operating room: report

by CM Staff   

Research & Development Technology / IIoT Electronics

By 2024, the market is estimated to grow more than three-fold, reaching US$225.4 million, finds Frost & Sullivan

PHOTO: Frost & Sullivan

SANTA CLARA, Calif. — Frost & Sullivan’s recent study, Growth Opportunities in Artificial Intelligence and Analytics in Surgery, 2020, finds that the permeation of artificial intelligence (AI) and analytics in operating rooms (ORs) will help hospitals achieve high potential.

By 2024, the market is estimated to grow more than three-fold, reaching $225.4 million from US$69.1 million in 2019, at a staggering compound annual growth rate (CAGR) of US26.7%.

However, due to the COVID-19 pandemic uncertainty, the adoption of AI and analytics solutions is expected to be slower in 2020, given that it will not be a priority for hospitals. Operational solutions that help hospitals manage their strained resources could still see higher adoption once the crisis subsides, according to Frost & Sullivan.

“Most existing OR challenges have been difficult to address, but the advent of AI and analytics technologies makes it simpler to address these with low investment,” said Siddharth Shah, transformational health program manager at Frost & Sullivan, in a prepared statement. “As is typically the case with such markets, the application areas are highly varied but distributed within two larger buckets — operational or administrative applications, and clinical applications.”


Shah added: “By 2025, there will be significant mergers and acquisitions (M&A) activity in this start-up-driven market, with medical technology (medtech) and medical imaging majors racing to build the most comprehensive solution portfolios to complement existing offerings. Further, operational offerings will be taken over by clinical offerings in terms of adoption and revenue-generation potential because of the proven value in improving patient outcomes and long-term studies, indicating a return on investment (ROI).”

Companies in the space should:

  • Leverage the power of disruptive technologies such as augmented reality (AR), virtual reality (VR), and robotics to build clinical offerings targeting new areas currently not being served.
  • Emphasize vertical integration beyond the operating room through partnerships, licensing, and M&A.
  • Focus on geographical expansion by collaborating or partnering with local agents, especially in Asia-Pacific.
  • Ensure implementation of and adherence to best practices for the operating room.


Stories continue below